Breaking News, Promotions & Moves

Gilead CMO to Step Down Next Year

Dr. Merdad Parsey leaves the company amid a proliferation of late-stage failures and development discontinuations.

Author Image

By: Charlie Sternberg

Associate Editor

Gilead Sciences Inc.’s Chief Medical Officer, Merdad Parsey, MD, PhD, will leave the company early next year. He will continue as CMO until the first quarter of 2025 and support this transition over the next several months while the company looks for a successor. “On behalf of everyone at Gilead, I want to thank Merdad for his significant contributions as our Chief Medical Officer over the last five years. These were pivotal years for the company as we worked to strengthen and diversify the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters